Your browser doesn't support javascript.
loading
Ferrous iron-activatable drug conjugate achieves potent MAPK blockade in KRAS-driven tumors.
Jiang, Honglin; Muir, Ryan K; Gonciarz, Ryan L; Olshen, Adam B; Yeh, Iwei; Hann, Byron C; Zhao, Ning; Wang, Yung-Hua; Behr, Spencer C; Korkola, James E; Evans, Michael J; Collisson, Eric A; Renslo, Adam R.
Afiliación
  • Jiang H; Division of Hematology and Oncology, Department of Medicine, University of California, San Francisco, San Francisco, CA.
  • Muir RK; Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, San Francisco, CA.
  • Gonciarz RL; Department of Pharmaceutical Chemistry, University of California, San Francisco, San Francisco, CA.
  • Olshen AB; Department of Pharmaceutical Chemistry, University of California, San Francisco, San Francisco, CA.
  • Yeh I; Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, San Francisco, CA.
  • Hann BC; Department of Epidemiology and Biostatistics, University of California, San Francisco, San Francisco, CA.
  • Zhao N; Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, San Francisco, CA.
  • Wang YH; Departments of Pathology and Dermatology, University of California, San Francisco, San Francisco, CA.
  • Behr SC; Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, San Francisco, CA.
  • Korkola JE; Department of Radiology and Biomedical Imaging, University of California, San Francisco, San Francisco, CA.
  • Evans MJ; Department of Radiology and Biomedical Imaging, University of California, San Francisco, San Francisco, CA.
  • Collisson EA; Department of Radiology and Biomedical Imaging, University of California, San Francisco, San Francisco, CA.
  • Renslo AR; Center for Spatial Systems Biomedicine, Oregon Health & Sciences University, Portland, OR.
J Exp Med ; 219(4)2022 04 04.
Article en En | MEDLINE | ID: mdl-35262628

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Proteínas Proto-Oncogénicas p21(ras) / Neoplasias Límite: Animals Idioma: En Revista: J Exp Med Año: 2022 Tipo del documento: Article País de afiliación: Canadá Pais de publicación: Estados Unidos

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Proteínas Proto-Oncogénicas p21(ras) / Neoplasias Límite: Animals Idioma: En Revista: J Exp Med Año: 2022 Tipo del documento: Article País de afiliación: Canadá Pais de publicación: Estados Unidos